Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: long-term follow-up of the STI571 0102 and 0109 trials.
Posted by rob on September 28, 2009 under Uncategorized | 
Comments are off for this article
  |
Related Articles |
Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: long-term follow-up of the STI571 0102 and 0109 trials.
Haematologica. 2009 May;94(5):743-4
Authors: Silver RT, Cortes J, Waltzman R, Mone M, Kantarjian H
PMID: 19407320 [PubMed - indexed for MEDLINE]